August 2025

B. Pharm / Pharm D or equivalent. Experience in Operations / Patient Care management 

PG in Life Sciences / Biology or an associated field, possesses National Eligibility Tests- CSIR UGC NET including Lectureship and GATE certificate or qualified National Level examination conducted by Central Government departments/agencies /institutions

B.Pharm or Equivalent from recognized Institution. The Blinatumomab Project has been envisioned as a multicentric project which facilitates treatment for relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in adults and children.

Postgraduate degree in Life Sciences / Biology or an associated field, possesses National Eligibility Tests- CSIR UGC NET including Lectureship and GATE certificate or qualified National Level examination conducted by Central Government departments

M.Sc. in Botany, Biotechnology, Biochemistry, Plant Science from a recognized University or equivalent.

Graduate Degree in Biotechnology or any Life Sciences subject from a recognized University or equivalent. Understanding the Molecular Mechanism in Ceramide Induced Pathological Activation of Nek7/Nlrp3-Inflammasome. 

Bachelor of Science (B.Sc) with biology as main subject, Bachelors in Engineering with biotechnology (MSc) with minimum 55% of total marks (equivalent grade) in Molecular biology, Genetics, Biochemistry, Biotechnology.

M. Sc. in Chemistry, Biotechnology, Microbiology, Bioinformatics. Work experience in synthesis of nanomaterials, nanocomposites, membrane design etc.

Masters degree in the bioinformatics or relevant disciplines, with demonstrated interest and experience in bioinformatic analysis and a strong computational background.